Literature DB >> 27770636

Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.

Jesse Mez1, Jaeyoon Chung2, Gyungah Jun3, Joshua Kriegel4, Alexandra P Bourlas4, Richard Sherva2, Mark W Logue5, Lisa L Barnes6, David A Bennett7, Joseph D Buxbaum8, Goldie S Byrd9, Paul K Crane10, Nilüfer Ertekin-Taner11, Denis Evans6, M Daniele Fallin12, Tatiana Foroud13, Alison Goate8, Neill R Graff-Radford11, Kathleen S Hall14, M Ilyas Kamboh15, Walter A Kukull16, Eric B Larson17, Jennifer J Manly18, Jonathan L Haines19, Richard Mayeux18, Margaret A Pericak-Vance20, Gerard D Schellenberg21, Kathryn L Lunetta22, Lindsay A Farrer23.   

Abstract

INTRODUCTION: African Americans' (AAs) late-onset Alzheimer's disease (LOAD) genetic risk profile is incompletely understood. Including clinical covariates in genetic analyses using informed conditioning might improve study power.
METHODS: We conducted a genome-wide association study (GWAS) in AAs employing informed conditioning in 1825 LOAD cases and 3784 cognitively normal controls. We derived a posterior liability conditioned on age, sex, diabetes status, current smoking status, educational attainment, and affection status, with parameters informed by external prevalence information. We assessed association between the posterior liability and a genome-wide set of single-nucleotide polymorphisms (SNPs), controlling for APOE and ABCA7, identified previously in a LOAD GWAS of AAs.
RESULTS: Two SNPs at novel loci, rs112404845 (P = 3.8 × 10-8), upstream of COBL, and rs16961023 (P = 4.6 × 10-8), downstream of SLC10A2, obtained genome-wide significant evidence of association with the posterior liability. DISCUSSION: An informed conditioning approach can detect LOAD genetic associations in AAs not identified by traditional GWAS.
Copyright © 2016 the Alzheimer's Association. All rights reserved.

Entities:  

Keywords:  ABCA7; APOE; African Americans; Age; Alzheimer's disease; COBL; Diabetes; Education; Genome-wide association study (GWAS); Informed conditioning on clinical covariates; Resveratrol; SLC10A2; Sex differences; Smoking

Mesh:

Substances:

Year:  2016        PMID: 27770636      PMCID: PMC5318231          DOI: 10.1016/j.jalz.2016.09.002

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  50 in total

1.  Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan.

Authors:  M X Tang; P Cross; H Andrews; D M Jacobs; S Small; K Bell; C Merchant; R Lantigua; R Costa; Y Stern; R Mayeux
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

2.  Comparison of Alzheimer's disease risk factors in white and African American families.

Authors:  D L Bachman; R C Green; K S Benke; L A Cupples; L A Farrer
Journal:  Neurology       Date:  2003-04-22       Impact factor: 9.910

3.  Analysis of the ileal bile acid transporter gene, SLC10A2, in subjects with familial hypertriglyceridemia.

Authors:  M W Love; A L Craddock; B Angelin; J D Brunzell; W C Duane; P A Dawson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-12       Impact factor: 8.311

4.  Dementia and Alzheimer disease incidence: a prospective cohort study.

Authors:  Walter A Kukull; Roger Higdon; James D Bowen; Wayne C McCormick; Linda Teri; Gerard D Schellenberg; Gerald van Belle; Lance Jolley; Eric B Larson
Journal:  Arch Neurol       Date:  2002-11

5.  A clinicopathological comparison of community-based and clinic-based cohorts of patients with dementia.

Authors:  F Massoud; G Devi; Y Stern; A Lawton; J E Goldman; Y Liu; S S Chin; R Mayeux
Journal:  Arch Neurol       Date:  1999-11

6.  Smoking affects the phenotype of Alzheimer disease.

Authors:  M N Sabbagh; S L Tyas; S C Emery; L A Hansen; M F Alford; R T Reid; P Tiraboschi; L J Thal
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

7.  Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana.

Authors:  H C Hendrie; A Ogunniyi; K S Hall; O Baiyewu; F W Unverzagt; O Gureje; S Gao; R M Evans; A O Ogunseyinde; A O Adeyinka; B Musick; S L Hui
Journal:  JAMA       Date:  2001-02-14       Impact factor: 56.272

8.  Natural history of mild cognitive impairment in older persons.

Authors:  D A Bennett; R S Wilson; J A Schneider; D A Evans; L A Beckett; N T Aggarwal; L L Barnes; J H Fox; J Bach
Journal:  Neurology       Date:  2002-07-23       Impact factor: 9.910

9.  Prevalence of dementia in three ethnic groups: the South Florida program on aging and health.

Authors:  Jasenka Demirovic; Ronald Prineas; David Loewenstein; Judy Bean; Ranjan Duara; Steven Sevush; Jose Szapocznik
Journal:  Ann Epidemiol       Date:  2003-07       Impact factor: 3.797

10.  Design of the Chicago Health and Aging Project (CHAP).

Authors:  Julia L Bienias; Laurel A Beckett; David A Bennett; Robert S Wilson; Denis A Evans
Journal:  J Alzheimers Dis       Date:  2003-10       Impact factor: 4.472

View more
  31 in total

Review 1.  TFEB dysregulation as a driver of autophagy dysfunction in neurodegenerative disease: Molecular mechanisms, cellular processes, and emerging therapeutic opportunities.

Authors:  Constanza J Cortes; Albert R La Spada
Journal:  Neurobiol Dis       Date:  2018-05-28       Impact factor: 5.996

Review 2.  Interpretation of risk loci from genome-wide association studies of Alzheimer's disease.

Authors:  Shea J Andrews; Brian Fulton-Howard; Alison Goate
Journal:  Lancet Neurol       Date:  2020-01-24       Impact factor: 44.182

Review 3.  Advances in the discovery of genetic risk factors for complex forms of neurodegenerative disorders: contemporary approaches, success, challenges and prospects.

Authors:  Sumeet Kumar; Navneesh Yadav; Sanjay Pandey; B K Thelma
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

4.  COBLL1 modulates cell morphology and facilitates androgen receptor genomic binding in advanced prostate cancer.

Authors:  Ken-Ichi Takayama; Takashi Suzuki; Tetsuya Fujimura; Satoru Takahashi; Satoshi Inoue
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-23       Impact factor: 11.205

5.  Assessment of Racial Disparities in Biomarkers for Alzheimer Disease.

Authors:  John C Morris; Suzanne E Schindler; Lena M McCue; Krista L Moulder; Tammie L S Benzinger; Carlos Cruchaga; Anne M Fagan; Elizabeth Grant; Brian A Gordon; David M Holtzman; Chengjie Xiong
Journal:  JAMA Neurol       Date:  2019-03-01       Impact factor: 18.302

6.  Transcriptional Alterations in Dorsolateral Prefrontal Cortex and Nucleus Accumbens Implicate Neuroinflammation and Synaptic Remodeling in Opioid Use Disorder.

Authors:  Marianne L Seney; Sam-Moon Kim; Jill R Glausier; Mariah A Hildebrand; Xiangning Xue; Wei Zong; Jiebiao Wang; Micah A Shelton; BaDoi N Phan; Chaitanya Srinivasan; Andreas R Pfenning; George C Tseng; David A Lewis; Zachary Freyberg; Ryan W Logan
Journal:  Biol Psychiatry       Date:  2021-06-12       Impact factor: 12.810

7.  The Big Picture of Neurodegeneration: A Meta Study to Extract the Essential Evidence on Neurodegenerative Diseases in a Network-Based Approach.

Authors:  Nicolas Ruffini; Susanne Klingenberg; Raoul Heese; Susann Schweiger; Susanne Gerber
Journal:  Front Aging Neurosci       Date:  2022-06-27       Impact factor: 5.702

8.  Progress and future challenges in aging and diversity research in the United States.

Authors:  Paul Brewster; Lisa Barnes; Mary Haan; Julene K Johnson; Jennifer J Manly; Anna María Nápoles; Rachel A Whitmer; Luis Carvajal-Carmona; Dawnte Early; Sarah Farias; Elizabeth Rose Mayeda; Rebecca Melrose; Oanh L Meyer; Adina Zeki Al Hazzouri; Ladson Hinton; Dan Mungas
Journal:  Alzheimers Dement       Date:  2018-09-19       Impact factor: 21.566

Review 9.  How understudied populations have contributed to our understanding of Alzheimer's disease genetics.

Authors:  Nadia Dehghani; Jose Bras; Rita Guerreiro
Journal:  Brain       Date:  2021-05-07       Impact factor: 13.501

10.  One for all and all for One: Improving replication of genetic studies through network diffusion.

Authors:  Daniel Lancour; Adam Naj; Richard Mayeux; Jonathan L Haines; Margaret A Pericak-Vance; Gerard D Schellenberg; Mark Crovella; Lindsay A Farrer; Simon Kasif
Journal:  PLoS Genet       Date:  2018-04-23       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.